Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Phase 2

Completed

• Conditions: Open-Angle Glaucoma; Ocular Hypertension

• Registration Number: NCT00069719
• Lead Sponsor: Alcon Research

Brief Summary

To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.

Detailed Description

Not available

Study Timeline

• Study Start: 1999-02
• Primary Completion: 2003-08
• Study Completion: 2003-08
• Study First Submitted: 2003-09-30
• Study First Submitted QC: 2003-10-03
• Study First Posted: 2003-10-06
• Status Verified: 2008-08
• Last Update Submitted: 2008-08-04
• Last Update Posted: 2008-08-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;
• logMAR visual acuity not worse than 0.6.

Exclusion Criteria

• Clinically relevant ophthalmic or systemic conditions may be excluded.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Alcon Clinical Trial Sites; 🇺🇸 Multiple Locations Throughout the US Sponsored by Alcon of, Texas, United States

Alcon Clinical Trial Sites

🇺🇸Multiple Locations Throughout the US Sponsored by Alcon of, Texas, United States